BRPI0915052A2 - compostos de 1,7-difenil-1,2,3,5,6,7-hexa-hidropirido [3,2,1-ij] quinolina substituído terapeuticamente úteis - Google Patents

compostos de 1,7-difenil-1,2,3,5,6,7-hexa-hidropirido [3,2,1-ij] quinolina substituído terapeuticamente úteis

Info

Publication number: BRPI0915052A2
Authority: BR; Brazil
Prior art keywords: hexahydropyrido; diphenyl; substituted; quinoline compounds; useful therapeutically
Prior art date: 2008-05-08

Application number

BRPI0915052A

Other languages

English (en)

Inventor

E Donello John

Chow Ken

L Beard Richard

C Sinha Santosh

S Bhat Smita

Original Assignee

Allergan Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-05-08

Filing date

2009-05-01

Publication date

2019-09-24

2009-05-01 Application filed by Allergan Inc filed Critical Allergan Inc

2019-09-24 Publication of BRPI0915052A2 publication Critical patent/BRPI0915052A2/pt

Links

LXEZOZSXUURBJG-UHFFFAOYSA-N ac1moj3z Chemical class C=12C3=CC=CC=1C(C=1C=CC=CC=1)CCN2CCC3C1=CC=CC=C1 LXEZOZSXUURBJG-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Ophthalmology & Optometry (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BRPI0915052A 2008-05-08 2009-05-01 compostos de 1,7-difenil-1,2,3,5,6,7-hexa-hidropirido [3,2,1-ij] quinolina substituído terapeuticamente úteis BRPI0915052A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5153308P	2008-05-08	2008-05-08
PCT/US2009/042474 WO2009137342A1 (en)	2008-05-08	2009-05-01	Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido [ 3, 2, 1-i j ] quinoline compounds

Publications (1)

Publication Number	Publication Date
BRPI0915052A2 true BRPI0915052A2 (pt)	2019-09-24

Family

ID=40852499

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0915052A BRPI0915052A2 (pt)	2008-05-08	2009-05-01	compostos de 1,7-difenil-1,2,3,5,6,7-hexa-hidropirido [3,2,1-ij] quinolina substituído terapeuticamente úteis

Country Status (10)

Country	Link
US (4)	US20100009985A1 (pt)
EP (1)	EP2300468A1 (pt)
JP (1)	JP2011519938A (pt)
KR (1)	KR20110025751A (pt)
CN (1)	CN102089305A (pt)
AU (1)	AU2009244538A1 (pt)
BR (1)	BRPI0915052A2 (pt)
CA (1)	CA2723775A1 (pt)
RU (1)	RU2010149311A (pt)
WO (1)	WO2009137342A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2014508813A (ja) *	2011-03-25	2014-04-10	アラーガンインコーポレイテッド	眼圧降下補助剤としてのｓ１ｐアンタゴニスト

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005519915A (ja) *	2002-01-18	2005-07-07	セレテック・リミテッド・ライアビリティ・カンパニー	Ｅｄｇ受容体に関連する症状の処置方法
ATE441654T1 (de)	2002-01-18	2009-09-15	Merck & Co Inc	Edg-rezeptoragonisten
US7208502B2 (en) *	2002-01-18	2007-04-24	Maniv Energy Capital	Methods of treating conditions associated with an Edg-3 receptor
OA12923A (en) *	2002-09-17	2006-10-13	Warner Lambert Co	Heterocyclic substituted piperazines for the treatment of schizophrenia.
US20040131648A1 (en)	2002-10-24	2004-07-08	The Procter & Gamble Company	Nuclear hormone receptor compounds, products and methods employing same
EP1594508B1 (en)	2003-02-11	2012-08-08	Irm Llc	Novel bicyclic compounds and compositions
ES2383298T3 (es)	2003-04-30	2012-06-20	Novartis Ag	Derivados del amino-propanol como moduladores del receptor esfingosina-1-fosfato
JP2006528980A (ja)	2003-05-15	2006-12-28	メルク　エンド　カムパニー　インコーポレーテッド	Ｓ１ｐ受容体作働薬としての３−（２−アミノ−１−アザシクロ）−５−アリール−１，２，４−オキサジアゾール類
MY150088A (en)	2003-05-19	2013-11-29	Irm Llc	Immunosuppressant compounds and compositions
EP2298770A1 (en) *	2005-11-03	2011-03-23	ChemBridge Corporation	Heterocyclic compounds as TrkA modulators
US8097644B2 (en) *	2006-03-28	2012-01-17	Allergan, Inc.	Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist

2009
- 2009-05-01 BR BRPI0915052A patent/BRPI0915052A2/pt not_active IP Right Cessation
- 2009-05-01 EP EP09743329A patent/EP2300468A1/en not_active Withdrawn
- 2009-05-01 CN CN200980126632XA patent/CN102089305A/zh active Pending
- 2009-05-01 RU RU2010149311/04A patent/RU2010149311A/ru unknown
- 2009-05-01 KR KR1020107027580A patent/KR20110025751A/ko not_active Withdrawn
- 2009-05-01 AU AU2009244538A patent/AU2009244538A1/en not_active Abandoned
- 2009-05-01 CA CA2723775A patent/CA2723775A1/en not_active Abandoned
- 2009-05-01 WO PCT/US2009/042474 patent/WO2009137342A1/en not_active Ceased
- 2009-05-01 JP JP2011508561A patent/JP2011519938A/ja active Pending
- 2009-05-07 US US12/437,138 patent/US20100009985A1/en not_active Abandoned
2011
- 2011-06-01 US US13/150,751 patent/US8188279B2/en not_active Expired - Fee Related
2012
- 2012-05-01 US US13/461,398 patent/US8309729B2/en not_active Expired - Fee Related
- 2012-08-08 US US13/569,418 patent/US8431702B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN102089305A (zh)	2011-06-08
KR20110025751A (ko)	2011-03-11
US20120309782A1 (en)	2012-12-06
WO2009137342A1 (en)	2009-11-12
US20110237797A1 (en)	2011-09-29
CA2723775A1 (en)	2009-11-12
RU2010149311A (ru)	2012-06-20
JP2011519938A (ja)	2011-07-14
US8188279B2 (en)	2012-05-29
US8431702B2 (en)	2013-04-30
AU2009244538A1 (en)	2009-11-12
EP2300468A1 (en)	2011-03-30
US20100009985A1 (en)	2010-01-14
US20120214838A1 (en)	2012-08-23
US8309729B2 (en)	2012-11-13

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application fees: application dismissed [chapter 8.6 patent gazette]
2020-01-21	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0914657A2 (pt)	2019-09-24	piridin-2-onae piridazin-3-onas substituídas
BRPI0918760A2 (pt)	2015-12-29	compostos morfinanos
DK2376490T3 (da)	2013-04-15	Imidazopyridinforbindelser
BR112012028519A2 (pt)	2016-07-19	compostos de 2,5,6,7-tetrahidro-[1,4]oxazepin-3-ilamina ou 2,3,6,7-tetrahidro-[1,4]oxazepin-5-ilamina
BRPI0907563A2 (pt)	2015-08-04	Derivados de 4,5-di-hidro-xazol-2-il amina
EP2376493A4 (en)	2012-05-30	DIHYDROPYRIMIDOPYRIMIDINDERIVAT
EP2380877A4 (en)	2012-06-27	PYRIDINE-3-CARBONSÄUREAMIDDERIVAT
BRPI0919948A2 (pt)	2015-08-25	Pirido[4,3-b]indois contendo porções rígidas
BRPI1014459A2 (pt)	2016-04-05	derivados de 3-(1,2,3-triazol-4-il)pirrolo[2,3-b]-piridina"
EP2336132A4 (en)	2012-03-21	MORPHOLINPURINDERIVAT
IL187904A0 (en)	2008-03-20	Quinoline derivatives as antibacterial agents
EP2344471A4 (en)	2012-05-30	7-PIPERIDINALKYL-3,4-dihydroquinolone DERIVATIVE
HUE052219T2 (hu)	2021-04-28	Eljárás kinolon vegyületek elõállítására
BRPI0914676A2 (pt)	2015-10-20	derivados de n-óxido de pirazina substituídos
DK2099762T3 (da)	2010-08-30	Antibakterielle quinolinderivater
AP2654A (en)	2013-04-25	Quinoline derivatives as antibacterial agents
BRPI0911443A2 (pt)	2015-10-06	derivados de aminopiridina
BRPI0916395A2 (pt)	2016-02-16	compostos de 1,6-di-hidro-2h-3-oxa-6-aza-as-indaceno
DK2099759T3 (da)	2011-08-15	Antibakterielle chinolinderivater
BRPI0909425A2 (pt)	2015-12-01	derivado de hidroxiquinoxalinacarboxamida
DK2792662T3 (da)	2016-07-25	Morphinanforbindelser
BRPI0912534A2 (pt)	2015-10-13	compostos de hidropirido [3,2,1-ij] quinolina substituído terapeuticamente úteis
IL188393A0 (en)	2008-08-07	Quinoline derivatives as antibacterial agents
BRPI0719939A2 (pt)	2014-03-11	Derivados de quinolina antibacterianos
DK2086941T3 (da)	2010-08-09	Antibakterielle quinolinderivater